Portfoliotracker

Metis TechBio Co., Ltd.

7666.HK · HKSE · Healthcare Biotechnology 64/100 C

7,285 HKD
▼ −1,180 (−13,94 %)
Closed delayed by 15 min
Price as of 17. 11. 09:08, fetched 17. 11. 15:16
Next earnings–
Ex-dividend–
Analysts–
50 / 200 day average– / –

Price

Portfoliotracker score64 / 100 Market cap8,62 mld. HKD P/E– Forward P/E-180,7 P/S33,4 P/B2,4 EV/EBITDA-23,4 Dividend yield– FCF yield– EPS-0,38 HKD Net margin-137,0 % Return on equity– Beta– Debt / equity0,06
52-week range 7,21 to 29,98
3-month average volume8,2 M

We do not have financial statements yet

The company reports in CNY, while the price is quoted in HKD. We do not convert statements between currencies yet, because the multiples (P/E, P/S and others) would come out wrong, so we do not show them here. You can see the price and its history above.

Fundamentals

Loading key figures…

Insiders, analysts and people

All trades and changes

Loading insiders, analysts and opinions…

Co se právě děje

AI souhrn
Objednat AI souhrn, co se u firmy právě děje Vytvoří se jednou na pozadí a pak ho uvidí všichni. Ve verzi Free 3 objednávky měsíčně.

About the company

Metis TechBio Co., Ltd. engages in research and development of AI-empowered nanomaterial for the delivery and application of active agents across carbon-based life forms in Chinese Mainland and United States. It develops NanoForge, a suite of synergistic technologies that includes novo lipid library, AI foundational models, METiSAIAgent, quantum chemistry and molecular dynamics simulations, and AI-driven screening platforms. The company also develops specialized platforms, such as AiTEM, AiLNP and AiRNA that simulate, predict, and interpret nanoscale interactions enabling the design, optimization, and validation of advanced nanomaterials and associated payloads. It offers foundational dry-wet data layer integrated dry-wet lab infrastructure; model layer METiS AI foundational models; and application layer METiSAgentv. It serves pharmaceutical companies, biotechnology companies, and medical research institutions. The company was formerly known as Hangzhou Jitai Pharmaceutical Technology Co., Ltd. Metis TechBio Co., Ltd. has a strategic partnership with Eli Lilly and Company. The company was incorporated in 2020 and is headquartered in Beijing, China.

Employees
150
Country
China
Data since
13. 5. 2026

Explore further

Similar companies 3696.HK6082.HK1879.HK

Intraday chart

Your own portfolio, properties and finances in one place.

The account is free with no time limit. Only you see your data; nobody adds it up with others.

This is saved to your account. You can keep browsing, calculating and comparing without signing in.

Welcome back

Sign in and pick up where you left off.

or continue with

No account yet? Create a free account